rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2003-7-15
|
pubmed:abstractText |
Intrathecal baclofen therapy (ITB) is a new tool in the integrated treatment of childhood spasticity. AIMS. We describe the eligibility and exclusion criteria used in the study and short term results of ITB therapy in our first five patients are also reported.
|
pubmed:language |
spa
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0210-0010
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
83-5
|
pubmed:dateRevised |
2009-5-28
|
pubmed:meshHeading |
pubmed-meshheading:12861517-Adolescent,
pubmed-meshheading:12861517-Baclofen,
pubmed-meshheading:12861517-Female,
pubmed-meshheading:12861517-Humans,
pubmed-meshheading:12861517-Injections, Spinal,
pubmed-meshheading:12861517-Male,
pubmed-meshheading:12861517-Muscle Spasticity,
pubmed-meshheading:12861517-Pain,
pubmed-meshheading:12861517-Quality of Life,
pubmed-meshheading:12861517-Treatment Outcome
|
pubmed:articleTitle |
[Intrathecal baclofen therapy: the selection of patients and short term results in five patients].
|
pubmed:affiliation |
Servicio de Neurología Pediátrica. Hospital Universitario Niño Jesus, Madrid, España. med019243@saludalia.com
|
pubmed:publicationType |
Journal Article,
English Abstract
|